STL Volume 2 Number 5
4 POSTS 0 COMMENTS
In this article, we examine the other approaches to PHN management. Claims have been made for products ranging from vitamins to snake venom for patients who develop PHN.
In April 1997, Apligraf® (Novartis), an in vitro construct of human skin (human skin equivalent HSE1), gained approval from the HPB in Canada for use in healing venous leg ulcers. This was the first major regulatory body to approve HSE for this indication.